Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Glbl E Regulatory News (JARE)

Share Price Information for Jpmorgan Glbl E (JARE)

Share Price is delayed by 15 minutes
Get Live Data
0.9175    0.00 (0.00%)
Bid:
0.835
Ask:
1.00
Spread: 0.165 (19.76%)
Market Cap: €26.30m
JARE Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Glbl E Share Chart

Fee Reduction

17 Jan 2022 07:00

RNS Number : 5399Y
JPMorgan Global Core Real Assets Ld
17 January 2022
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

 

Fee Reduction

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

 

JPMorgan Global Core Real Assets Limited ("JARA" or "the Company") has received a notification that one of the underlying strategies that it is invested in has reduced its fees as a result of the strategy reaching a certain threshold of assets under management ("AUM") and so is passing the associated economies of scale onto its investors. JARA is delighted to be able to pass this fee reduction, expected to be valid from 1 January 2022, onto its investors. The benefit of this to JARA's overall management fee is detailed below compared to the most recent fee mix as described in the 2021 annual report.

 

JARA's Fee mix based on net assets

 

JARA Size

(Net Assets)

Pre Fee reductioon as per 2021 annual report*

 

Post fee reduction*

£100m

0.97%

0.93%

£300m

0.95%

0.91%

£500m

0.90%

0.86%

£1,000m

0.85%

0.81%

* Based on JARA's current strategic asset allocation

Calculation based on GBP/USD exchange rate: 1/1.35

 

At JARA's current net assets of c.£206m the fee based on JARA's current strategic asset allocation would be 0.92%. To the extent JARA's allocation differs from its strategic asset allocation this may impact the total fee payable.

 

This is the third fee cut JARA has seen from its underlying strategies since launch and shows the benefit of being able to invest into private vehicles that provide scale, diversification and lower fees as they reach significant AUM milestones. We view this fee cut as continuing to demonstrate the strength of JARA's ability to access private institutional quality funds at an attractive fee rate.

 

Company Information - Fee

 

The total overall management fee payable to JPMAM is the aggregate of the management fee charged by the underlying strategies and the Company level management fee calculated at the rate of 0.05 per cent per annum. but does not include any performance fees charged by the underlying strategies.

 

17th January 2022

 

Alison Vincent

JPMorgan Funds Limited - Company Secretary

Telephone 0207 742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFIFMLEESELF
Date   Source Headline
1st Jun 202611:34 amRNSTotal Voting Rights
12th May 20265:12 pmRNSDirector/PDMR Shareholding
8th May 20264:13 pmRNSDirector/PDMR Shareholding
8th May 20264:12 pmRNSDirector/PDMR Shareholding
7th May 20269:09 amRNSMonthly Portfolio Update
5th May 20261:14 pmRNSHolding(s) in Company
1st May 20267:00 amRNSFOURTH COMPULSORY PARTIAL REDEMPTION OF SHARES
15th Apr 20267:00 amRNSFOURTH COMPULSORY PARTIAL REDEMPTION OF SHARES
7th Apr 20267:00 amRNSMonthly Portfolio Update
16th Mar 202610:22 amRNSQuarterly Net Asset Value and Portfolio Update
10th Mar 20263:32 pmRNSDirector/PDMR Shareholding
5th Mar 20265:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20262:17 pmRNSClosed period notification
2nd Mar 202612:56 pmRNSHolding(s) in Company
23rd Feb 20265:07 pmRNSHolding(s) in Company
20th Feb 20269:45 amRNSMonthly Portfolio Update
17th Feb 20265:38 pmRNSDirector/PDMR Shareholding
16th Feb 202612:29 pmRNSDirector/PDMR Shareholding
12th Feb 202610:48 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSTHIRD COMPULSORY PARTIAL REDEMPTION OF SHARES
26th Jan 20265:50 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSTHIRD COMPULSORY PARTIAL REDEMPTION OF SHARES
12th Jan 20265:07 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSMonthly Portfolio Update
11th Dec 202510:14 amRNSQuarterly NAV and Portfolio Update
28th Nov 20257:00 amRNSHalf-year Financial Report
18th Nov 20257:00 amRNSMonthly Portfolio Update
14th Oct 20257:00 amRNSMonthly Portfolio Update
17th Sep 20251:14 pmRNSBlock listing Interim Review
17th Sep 202512:57 pmRNSClosed Period Notification
17th Sep 20257:00 amRNSQUARTERLY NET ASSET VALUE AND PORTFOLIO UPDATE
5th Sep 20259:15 amRNSDirector/PDMR Shareholding
1st Sep 20255:11 pmRNSHolding(s) in Company
1st Sep 202510:12 amRNSTotal Voting Rights
29th Aug 202510:25 amRNSHolding(s) in Company
28th Aug 20253:58 pmRNSResult of AGM
27th Aug 202511:12 amRNSDirector Declaration
19th Aug 20255:38 pmRNSHolding(s) in Company
15th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 20254:35 pmRNSDirector/PDMR Shareholding
11th Aug 20254:18 pmRNSDirector/PDMR Shareholding
11th Aug 20254:17 pmRNSDirector/PDMR Shareholding
8th Aug 20257:00 amRNSSECOND COMPULSORY PARTIAL REDEMPTION OF SHARES
7th Aug 20257:00 amRNSMonthly Portfolio Update
22nd Jul 20257:00 amRNSSECOND COMPULSORY PARTIAL REDEMPTION OF SHARES
9th Jul 20257:00 amRNSMonthly Portfolio Update
3rd Jul 202511:30 amRNSHolding(s) in Company
2nd Jul 20257:00 amRNSQuarterly Net Asset Value & Portfolio Update
30th Jun 20253:49 pmRNSFinal results for the year ended 28 February 2025
24th Jun 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.